Documents
Application Sponsors
Marketing Status
| Prescription | 001 |
| Prescription | 002 |
| Discontinued | 003 |
| Prescription | 004 |
Application Products
| 001 | TABLET;ORAL | 5MG | 1 | LEVITRA | VARDENAFIL HYDROCHLORIDE |
| 002 | TABLET;ORAL | 10MG | 1 | LEVITRA | VARDENAFIL HYDROCHLORIDE |
| 003 | TABLET;ORAL | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | 1 | LEVITRA | VARDENAFIL HYDROCHLORIDE |
| 004 | TABLET;ORAL | 20MG | 1 | LEVITRA | VARDENAFIL HYDROCHLORIDE |
FDA Submissions
| TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 2003-08-19 | STANDARD |
| LABELING; Labeling | SUPPL | 2 | AP | 2005-05-13 | STANDARD |
| LABELING; Labeling | SUPPL | 4 | AP | 2005-07-08 | STANDARD |
| LABELING; Labeling | SUPPL | 8 | AP | 2007-04-06 | STANDARD |
| LABELING; Labeling | SUPPL | 10 | AP | 2007-10-18 | STANDARD |
| LABELING; Labeling | SUPPL | 11 | AP | 2008-03-19 | STANDARD |
| LABELING; Labeling | SUPPL | 12 | AP | 2008-05-15 | STANDARD |
| LABELING; Labeling | SUPPL | 13 | AP | 2011-11-22 | STANDARD |
| EFFICACY; Efficacy | SUPPL | 16 | AP | 2013-08-02 | STANDARD |
| LABELING; Labeling | SUPPL | 17 | AP | 2014-04-29 | STANDARD |
| MANUF (CMC); Manufacturing (CMC) | SUPPL | 18 | AP | 2014-11-03 | STANDARD |
| LABELING; Labeling | SUPPL | 19 | AP | 2015-09-16 | STANDARD |
| LABELING; Labeling | SUPPL | 20 | AP | 2017-08-16 | STANDARD |
Submissions Property Types
| SUPPL | 13 | Null | 7 |
| SUPPL | 16 | Null | 6 |
| SUPPL | 17 | Null | 7 |
| SUPPL | 18 | Null | 0 |
| SUPPL | 19 | Null | 15 |
| SUPPL | 20 | Null | 15 |
TE Codes
| 001 | Prescription | AB |
| 002 | Prescription | AB |
| 004 | Prescription | AB |
CDER Filings
cder:Array
(
[0] => Array
(
[ApplNo] => 21400
[companyName] =>
[docInserts] => ["",""]
[products] => []
[labels] =>
[originalApprovals] => []
[supplements] =>
[actionDate] => 0000-00-00
)
)